NI201000215A - NUEVOS DERIVADOS DE (PIPERAZINILO CON ENLACES PUENTE )- 1 - ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75. - Google Patents
NUEVOS DERIVADOS DE (PIPERAZINILO CON ENLACES PUENTE )- 1 - ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75.Info
- Publication number
- NI201000215A NI201000215A NI201000215A NI201000215A NI201000215A NI 201000215 A NI201000215 A NI 201000215A NI 201000215 A NI201000215 A NI 201000215A NI 201000215 A NI201000215 A NI 201000215A NI 201000215 A NI201000215 A NI 201000215A
- Authority
- NI
- Nicaragua
- Prior art keywords
- piperazinyl
- alcanone
- inhibitors
- new derivatives
- bridge links
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
La invención se refiere a los derivados de ((feni1) - 3,6 - dihidropiridin - 1 - il) - (piperazinil con enlaces puente) -1- alcanona y ((fenil) - 2,5 - dihidro - pirrol - 1 - il) - (piperazinil con enlaces puente) - 1 - alcanona, de fórmula general (I) en la que A, B, m, W, n y R5 son tal como se definen en la reivindicación 1, así como su procedimiento de preparación y su aplicación en terapéutica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0803299A FR2932482B1 (fr) | 2008-06-13 | 2008-06-13 | Nouveaux derives de (phenyl-3,6-dihydro-2h-pyridinyl)- (piperazinyl ponte)-1-alcanone et leur utilisation comme inhibiteurs de p75 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI201000215A true NI201000215A (es) | 2011-05-04 |
Family
ID=40305395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI201000215A NI201000215A (es) | 2008-06-13 | 2010-12-10 | NUEVOS DERIVADOS DE (PIPERAZINILO CON ENLACES PUENTE )- 1 - ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75. |
Country Status (39)
| Country | Link |
|---|---|
| US (2) | US8193190B2 (es) |
| EP (1) | EP2297148B8 (es) |
| JP (1) | JP5476373B2 (es) |
| KR (1) | KR101642526B1 (es) |
| CN (1) | CN102124006B (es) |
| AR (1) | AR072103A1 (es) |
| AT (1) | ATE540039T1 (es) |
| AU (1) | AU2009259121B2 (es) |
| BR (1) | BRPI0915126B8 (es) |
| CA (1) | CA2727669C (es) |
| CL (1) | CL2010001429A1 (es) |
| CO (1) | CO6280535A2 (es) |
| CR (1) | CR11832A (es) |
| CY (1) | CY1112610T1 (es) |
| DK (1) | DK2297148T3 (es) |
| DO (2) | DOP2010000380A (es) |
| EA (1) | EA019074B1 (es) |
| EC (1) | ECSP10010672A (es) |
| ES (1) | ES2379685T3 (es) |
| FR (1) | FR2932482B1 (es) |
| HK (1) | HK1158631A1 (es) |
| HR (1) | HRP20120290T1 (es) |
| IL (1) | IL209902A (es) |
| JO (1) | JO2774B1 (es) |
| MA (1) | MA32474B1 (es) |
| MX (1) | MX2010013695A (es) |
| MY (1) | MY150988A (es) |
| NI (1) | NI201000215A (es) |
| NZ (1) | NZ589840A (es) |
| PE (1) | PE20110154A1 (es) |
| PL (1) | PL2297148T3 (es) |
| PT (1) | PT2297148E (es) |
| RS (1) | RS52262B (es) |
| SI (1) | SI2297148T1 (es) |
| SV (1) | SV2010003755A (es) |
| TW (1) | TWI432433B (es) |
| UA (1) | UA101979C2 (es) |
| UY (1) | UY31893A (es) |
| WO (1) | WO2009150388A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2931223B1 (fr) | 2008-05-16 | 2010-08-20 | Air Liquide | Dispositif distributeur de gaz sous pression, ensemble comprenant un tel dispositif et dispositif de commande, recipient pourvu d'un tel dispositif distributeur |
| FR2932481B1 (fr) * | 2008-06-13 | 2010-10-08 | Sanofi Aventis | Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique. |
| FR2953839A1 (fr) | 2009-12-14 | 2011-06-17 | Sanofi Aventis | Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75 |
| FR2953836B1 (fr) | 2009-12-14 | 2012-03-16 | Sanofi Aventis | Nouveaux derives (heterocycle-tetrahydro-pyridine)-(piperazinyl)-1-alcanone et (heterocycle-dihydro-pyrrolidine)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75 |
| EP2606894A1 (en) | 2011-12-20 | 2013-06-26 | Sanofi | Novel therapeutic use of p75 receptor antagonists |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3236243A1 (de) * | 1982-09-30 | 1984-04-05 | Merck Patent Gmbh, 6100 Darmstadt | Schwefelhaltige indolderivate |
| FR2744448B1 (fr) * | 1996-02-02 | 1998-04-24 | Pf Medicament | Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments |
| US6613942B1 (en) * | 1997-07-01 | 2003-09-02 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
| JP2003514508A (ja) * | 1997-07-01 | 2003-04-15 | ノボ ノルディスク アクティーゼルスカブ | グルカゴン拮抗剤／逆作用剤 |
| AU4198400A (en) | 1999-04-06 | 2000-10-23 | Krenitsky Pharmaceuticals Inc. | Neurotrophic thio substituted pyrimidines |
| UA77526C2 (en) * | 2002-06-07 | 2006-12-15 | Sanofi Aventis | Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy |
| FR2862968B1 (fr) * | 2003-12-01 | 2006-08-04 | Sanofi Synthelabo | Derives de 4-[(arylmethyl)aminomethyl]piperidine, leur preparation et leur application en therapeutique |
| FR2862967B1 (fr) * | 2003-12-01 | 2006-08-04 | Sanofi Synthelabo | Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique |
| FR2932481B1 (fr) | 2008-06-13 | 2010-10-08 | Sanofi Aventis | Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique. |
-
2008
- 2008-06-13 FR FR0803299A patent/FR2932482B1/fr not_active Expired - Fee Related
-
2009
- 2009-06-04 JO JO2009204A patent/JO2774B1/en active
- 2009-06-11 AR ARP090102110A patent/AR072103A1/es active IP Right Grant
- 2009-06-11 TW TW098119564A patent/TWI432433B/zh active
- 2009-06-12 CN CN200980131366.XA patent/CN102124006B/zh active Active
- 2009-06-12 JP JP2011513038A patent/JP5476373B2/ja active Active
- 2009-06-12 EA EA201170016A patent/EA019074B1/ru not_active IP Right Cessation
- 2009-06-12 PT PT09761939T patent/PT2297148E/pt unknown
- 2009-06-12 EP EP09761939A patent/EP2297148B8/fr active Active
- 2009-06-12 UY UY0001031893A patent/UY31893A/es not_active Application Discontinuation
- 2009-06-12 SI SI200930220T patent/SI2297148T1/sl unknown
- 2009-06-12 AT AT09761939T patent/ATE540039T1/de active
- 2009-06-12 NZ NZ589840A patent/NZ589840A/xx not_active IP Right Cessation
- 2009-06-12 RS RS20120137A patent/RS52262B/en unknown
- 2009-06-12 AU AU2009259121A patent/AU2009259121B2/en active Active
- 2009-06-12 MX MX2010013695A patent/MX2010013695A/es active IP Right Grant
- 2009-06-12 KR KR1020117000792A patent/KR101642526B1/ko active IP Right Grant
- 2009-06-12 PL PL09761939T patent/PL2297148T3/pl unknown
- 2009-06-12 MY MYPI20105850 patent/MY150988A/en unknown
- 2009-06-12 DK DK09761939.9T patent/DK2297148T3/da active
- 2009-06-12 UA UAA201100370A patent/UA101979C2/ru unknown
- 2009-06-12 ES ES09761939T patent/ES2379685T3/es active Active
- 2009-06-12 WO PCT/FR2009/051118 patent/WO2009150388A1/fr active Application Filing
- 2009-06-12 BR BRPI0915126A patent/BRPI0915126B8/pt active Search and Examination
- 2009-06-12 PE PE2010001120A patent/PE20110154A1/es not_active Application Discontinuation
- 2009-06-12 CA CA2727669A patent/CA2727669C/fr active Active
-
2010
- 2010-12-08 DO DO2010000380A patent/DOP2010000380A/es unknown
- 2010-12-08 CR CR11832A patent/CR11832A/es unknown
- 2010-12-09 IL IL209902A patent/IL209902A/en active IP Right Grant
- 2010-12-09 SV SV2010003755A patent/SV2010003755A/es unknown
- 2010-12-10 NI NI201000215A patent/NI201000215A/es unknown
- 2010-12-10 EC EC2010010672A patent/ECSP10010672A/es unknown
- 2010-12-13 CO CO10156029A patent/CO6280535A2/es active IP Right Grant
- 2010-12-13 CL CL2010001429A patent/CL2010001429A1/es unknown
- 2010-12-13 US US12/966,413 patent/US8193190B2/en active Active
-
2011
- 2011-01-13 MA MA33517A patent/MA32474B1/fr unknown
- 2011-11-29 HK HK11112930.5A patent/HK1158631A1/xx not_active IP Right Cessation
-
2012
- 2012-04-02 HR HR20120290T patent/HRP20120290T1/hr unknown
- 2012-04-04 CY CY20121100339T patent/CY1112610T1/el unknown
- 2012-05-17 US US13/473,885 patent/US8519143B2/en active Active
-
2013
- 2013-06-04 DO DO2013000124A patent/DOP2013000124A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP11010742A (es) | Derivados de piridino-piridinonas, su preparación y su aplicación en terapéutica | |
| ECSP14013245A (es) | Nuevos derivados dihidroquinolina-2-ona | |
| ECSP12011654A (es) | Derivados de 5-fluoropirimidinona | |
| ECSP10010334A (es) | Derivados de quinolina y su uso como fungicidas | |
| ECSP099791A (es) | Derivados de 7-alquinil-1,8-naftiridonas, su preparación y su aplicación en terapéutica | |
| CR20110381A (es) | Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2 | |
| ECSP12011651A (es) | Derivados de 5-fluoro-2-oxopirimidina-1(2h)-carboxilato | |
| ATE528290T1 (de) | Spiroindolinon-derivate | |
| CO6551705A2 (es) | Derivados de 3.4.4a.10b- tetrahidro-1h-tiopirano-[4.3-c]- isoquinolina | |
| EA201270256A1 (ru) | Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида | |
| ECSP12011653A (es) | Derivados de n1-acil-5-fluoropirimidinona | |
| DOP2013000124A (es) | NUEVOS DERIVADOS DE (PIPERAZINILO CON ENLACES PUENTE)-1-ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75. | |
| CR20110246A (es) | Derivados de carbamatos de alquil-heterociclos, su preparación y su aplicación en terapéutica. | |
| EA201170585A1 (ru) | Производные изохинолинона в качестве антагонистов nk3 | |
| EA200801549A1 (ru) | Новые производные фенантридина в качестве антагонистов брадикинина | |
| UY29631A1 (es) | Derivados del 4,5-diarilpirrol, su preparación y su aplicación en terapéutica | |
| EA200702428A1 (ru) | Способы получения 4-бифенилилазетидин-2-онов | |
| CO6501125A2 (es) | Nuevos derivados (heterociclico-tetrahidro-piridin)-(piperazinil)-1- alcanona y (heterociclo-dhidro-pirrolidin)-(piperazinil)-1-alcanona y su utilización como inhibidores de p75 | |
| UY29691A1 (es) | Derivados de n-(arilalquil)-1h-pirrolopiridin-2-carboxamidas, su preparación y su aplicación en terapéutica. |